Wednesday, February 10, 2010, 2:20am EST - Canadian Markets open in 7 hours and 10 minutes.
To create a watchlist or portfolio of shares, Sign-in or Register

Dendreon Corp. (DNDN)

 On Feb 9: 29.44 USD  Up 0.55 (1.90%)  
MORE ON DNDN
Quotes
HereSummary
Charts
News & Info
Company
Analyst Coverage
Ownership
Financials
Dendreon Corporation (NGM:DNDN) Delayed quote dataEdit
After Hours: 29.36 Down 0.08 (0.27%) as of 5:00pm EST on 02/09/10
Last Trade: 29.44 USD
Trade Time: Feb 9
Change: Up 0.55 (1.90%)
Prev Close: 28.89
Open: 29.16
Bid: 29.25 x 200
Ask: 29.49 x 200
1y Target Est: 36.44
Day's Range: 28.95 - 29.51
52wk Range: 2.55 - 30.90
Volume: 1,529,770
Avg Vol (3m): 2,244,100
Market Cap: 3.41B
P/E (ttm): N/A
EPS (ttm): -1.92
Div & Yield: N/A (N/A%)
Dendreon Corp. (DNDN)
1d  5d  3m  6m  1y  2y  5y  max 
 Add DNDN to Portfolio   Download Data

HEADLINES
• This Stock Has Tremendous Upside
at Motley Fool (Tue 1:30pm)
• 5-Star Stocks Poised to Pop: ISTA Pharmaceuticals
at Motley Fool (Tue 9:44am)
• An Earnings Surprise of an Unusual Kind
at Motley Fool (Mon, Feb 8)
• 4 Winning Biotechs For Your Portfolio: Senior Analyst
at CNBC (Mon, Feb 8)
• Is Biotech Back?
CNBC (Mon, Feb 8)
• [video] Is Biotech Back?
at CNBC (Mon, Feb 8)
• There's No Such Thing as an ETF Bubble
at TheStreet.com (Mon, Feb 8)
• 4-Star Stocks Poised to Pop: Myriad Genetics
at Motley Fool (Thu, Feb 4)
• Dendreon Announces Webcast Presentation at 12th Annual BIO CEO and Investor Conference
PRNewswire (Wed, Feb 3)
• Ground Floor -- Going Up!
at Motley Fool (Tue, Feb 2)
• Dendreon: To Short or Not to Short?
at Seeking Alpha (Tue, Feb 2)
• Barron's: new drugs could help industry sales, shares
at Reuters (Sun, Jan 31)
More Headlines for DNDN...
ANALYST
EPS Est (next year) (Dec-09) : -1.71
EPS Est (in 2 years) (Dec-10) : -0.60
Avg Rec (current)*: 1.5
PEG Ratio: N/A
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
Analyst Opinion - Estimates

BUSINESS SUMMARY
Dendreon Corporation, a biotechnology company, engages in the discovery, development, and commercialization of therapeutics to enhance cancer treatment options for patients.

Full Company Profile

Add to My Portfolio Add to Portfolio    Email to a Friend Email to a Friend
Get Summary for Another Symbol:
Symbol Lookup
• Latest News • Canadian Indices